Clinical Trial Update: A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects [Phase 1]

View source ↗

Summary

This listing describes a Phase 1 clinical trial evaluating Cemsidomide in combination with Elranatamab for relapsed/refractory multiple myeloma, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cemsidomide (Cemsidomide)
• Elranatamab (elranatamab)

Snippet

Sponsor: C4 Therapeutics, Inc. | Conditions: Multiple Myeloma (MM) | Phase 1 | Status: RECRUITING